Literature DB >> 20843118

Chemopreventive and anticarcinogenic effects of Momordica charantia extract.

R C Agrawal1, Tripti Beohar.   

Abstract

The aim of the study was to examine whether Momordica fruit extract (MFE) and Momordica leaves extract (MLE) might exert any chemopreventive effect in a two stage protocol in skin carcinogenesis with Swiss albino mice. The tumour incidence, tumour yield, tumour burden and cumulative no. of papillomas were found to be higher in the controls (without either extract) as compared to the MFE or MLE treated experimental groups. In a melanoma model, the mice which received fruit and leaf extracts of Momordica at the doses of 500 and 1000 mg/kg body weight for 30 days showed increase in life span of animals and tumour volume was significantly reduced as compared to control values. In cytogenetic studies, a single application of Momordica extracts at doses of 500, 1000 and 1500 mg/kg body weight, 24 hours prior the i.p. administration of cyclophosphamide, significantly prevented micronucleus formation and chromosomal aberrations in a dose dependent manner in bone marrow cells of mice. The present study demonstrate chemopreventive potential of Momordica fruit and leaf extracts on DMBA induced skin tumorigenesis, melanoma tumour and cytogenicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843118

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  10 in total

Review 1.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

Review 2.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

3.  Antibacterial and Antiproliferative Activities of Plumericin, an Iridoid Isolated from Momordica charantia Vine.

Authors:  Jutamas Saengsai; Sumonthip Kongtunjanphuk; Nuttawan Yoswatthana; Tanawan Kummalue; Weena Jiratchariyakul
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-07       Impact factor: 2.629

Review 4.  Recent Advances in Momordica charantia: Functional Components and Biological Activities.

Authors:  Shuo Jia; Mingyue Shen; Fan Zhang; Jianhua Xie
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

5.  Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model.

Authors:  Md Saddam Hussain; Nusrat Jahan; Md Mamun Or Rashid; Mohammad Salim Hossain; Umay Chen; Naimur Rahman
Journal:  Heliyon       Date:  2019-05-17

Review 6.  Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy.

Authors:  Subhayan Sur; Ratna B Ray
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

7.  Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products.

Authors:  Esin AkyÜz; Sercan TÜrkoĞlu; Kevser SÖzgen BaŞkan; Esma TÜtem; Mustafa Reşat Apak
Journal:  Turk J Chem       Date:  2020-12-16       Impact factor: 1.239

Review 8.  Overview of Botanical Status in EU, USA, and Thailand.

Authors:  Weena Jiratchariyakul; Gail B Mahady
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-21       Impact factor: 2.629

Review 9.  The therapeutic potential of medicinal foods.

Authors:  Nelvana Ramalingum; M Fawzi Mahomoodally
Journal:  Adv Pharmacol Sci       Date:  2014-04-17

Review 10.  Applicability of Plant Extracts in Preclinical Studies of Melanoma: A Systematic Review.

Authors:  Kamylla Rafaella Sena Albuquerque; Nívea Maria Pacheco; Thalia Del Rosario Loyo Casao; Fabiana Cristina Silveira Alves de Melo; Rômulo Dias Novaes; Reggiani Vilela Gonçalves
Journal:  Mediators Inflamm       Date:  2018-07-26       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.